ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Regor Therapeutics Announces Completion of $90 Million Series B Financing
February 19, 2021Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing. -
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million
November 09, 2020Inmagene Biopharmaceuticals, announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors.
Pharma Sources Insight January 2025
